Skip to main content

Table 1 Baseline characteristics of the patients (N = 229)

From: Radiographic progression can still occur in individual patients with low or moderate disease activity in the current treat-to-target paradigm: real-world data from the Dutch Rheumatoid Arthritis Monitoring (DREAM) registry

Characteristicsn 
Female, n (%)229145 (63.3)
Age, mean ± SD years22957.5 ± 15.0
BMI, mean ± SD kg/m222026.4 ± 4.6
Symptom duration, median (IQR) weeks22813.0 (8.0–26.0)
RF positive, n (%)228140 (61.4)
Anti-CCP positive, n/total (%)221130 (58.8)
Fulfillment of ACR 1987 criteria, n/total (%)225178 (79.0)
Erosion ≥ 1 joint226102 (46.6)
DAS28-ESR, mean ± SD2294.9 ± 1.1
# of tender joints (28 assessed), median (IQR)2295 (2–10)
# of swollen joints (28 assessed), median (IQR)2298 (4–12)
ESR, median (IQR) mm/h22928.0 (16.0–42.0)
CRP, median (IQR) mg/l22912.0 (5.0–29.3)
VAS general health, median (IQR) 0–100 VAS22950 (30.0–66.5)
VAS pain, median (IQR) 0–100 VAS22950 (37.0–69.5)
VAS fatigue, median (IQR) 0–100 VAS12450 (24.3–71.5)
HAQ-DI, median (IQR)1911.1 (0.6–1.5)
SF-36 PCS, median (IQR)19935.4 (30.0–41.5)
SF-36 MCS, median (IQR)19947.9 (39.0–56.4)
  1. BMI body mass index, IQR interquartile range, RF rheumatoid factor, ACR American College of Rheumatology, DAS28 disease activity score based on 28-joint count, ESR erythrocyte sedimentation rate, CRP C-reactive protein, VAS visual analog scale, HAQ Health Assessment Questionnaire, SF36 Short-Form 36 Health Survey, PCS physical component summary, MCS mental component summary